The price of this share is at 55,69$, In this post we are going to talk about the listed company Crispr Therapeutics AG, its leaders are Lawrence O. Klein (Chief Operating & Business Officer), Michael John Tomsicek (Chief Financial & Accounting Officer), Samarth Kulkarni (Chief Executive Officer & Director), Stephen R. Kennedy (Head-Technical Operations), Tony W. Ho (Executive VP, Head-Research & Development), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the Europe region.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 54,95$ moving between 51,95$ and 57,95$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
